The PennZone

  • Home
  • Business
  • Health
  • Financial
  • Construction
  • Automotive
  • Technology
  • Music
  • Arts

ExpressCells to Present in BIO Start-Up Stadium Next Week
The PennZone/10070540

Trending...
  • Safe Health Zones: A Global Breakthrough to Protect Night-Shift Workers from Preventable Harm
  • Schemawriter.ai launches WordPress plugin as industry leaders confirm - schema markup is critical
  • Sweet Memories Vintage Tees Debuts Historic ORCA™ Beverage Nostalgic Soda Collection
Company is one of 30 selected for prestigious competition. During BIO Digital Week, attendees can watch timely, on-demand pitches and meet with ExpressCells via BIO's One-on-One Partnering.

PHILADELPHIA - PennZone -- ExpressCells, Inc. (ExpressCells), a privately-owned genetic engineering company that creates knock-in cell lines for drug discovery, will be one of the finalists presenting in the Start-Up Stadium during BIO Digital Week.

"We are honored to be selected by the judges as one of the finalists for Start-Up Stadium. We hope that all BIO Digital Week attendees view our presentation, which will be available on demand via the meeting platform."

Start-Up Stadium provides an exciting and interactive experience where key stakeholders of the early-stage life science community, investors, and strategic partners provide feedback and judge 6 minute pitches presented by start-up biotech companies. During BIO Digital Week, attendees can watch ExpressCells' pitch on-demand and meet with the company via BIO's One-on-One Partnering.

More on The PennZone
  • Stratum Nutrition's OVOLUX™ Named 2025 "Collagen Ingredient of the Year" by Beauty Innovation Awards
  • Sons of Liberty Museum Unveils "America at 250" Mobile Exhibit on Veterans Day 2025
  • Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Bent Danholm Releases New Video Breaking Down the Rising Debate Over 50-Year Mortgages
  • New Smile Now Introduces RAYFace 3D Scanner to Advance Digital Surgery

"ExpressCells is excited to be part of BIO Digital Week," Mr. Handel continued. "We hope to gain valuable feedback and to meet with both potential customers and potential investors.

About ExpressCells

ExpressCells is a private biotechnology company based in Philadelphia, PA. Its propriety genome editing technology, in combination with CRISPR/Cas9, creates advanced, knock-in cell line up to 75% faster than older processes. This technology allows ExpressCells to insert up to three genes into the same cell line.

ExpressCells' first knock-in cell lines code for bioluminescent and fluorescent proteins. These allow scientists to more see the results of their experiments in real time. ExpressCells sells both custom cell lines—each designed to meet the specific requirements of an individual scientist—and catalog cell lines. For more information, visit www.xpresscells.com.

Contact
Matthew Handel
***@xpresscells.com
+1 (484) 483-6759


Source: ExpressCells, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Siembra Brings 18 Latinx Artists Together in Brooklyn Exhibition
  • Gramercy Tech Launches StoryStream
  • Entrigue Magazine LLC Announces Strategic Media Partnership with Reewind Network LLC
  • Turbo vs. Experts: Tracking OddsTrader's AI Performance at the NFL's Midpoint
  • Outreaching.io Appoints Rameez Ghayas Usmani as CEO, Recognized as Best HARO Link Building Expert in the United States
  • Winzele: A Trusted Isolation Transformer Manufacturer
  • Luxury Mediterranean Estate in Gotha Sells for $1.52 Million, Closing $45,000 Over Asking
  • ZEELOOL's Black Friday Sale Starts Early with Up to 80% Off Frames
  • UV Weathering Test Chamber vs Xenon Arc Test Chamber: What's the Right Solution for Your Products
  • Emeritus Addresses Hospital Bed Shortages with Smart Storage Solutions
  • Fulton County & Grow Your World Amplify Atlanta Youth Through the Youth Audio Collective
  • 2026 Oscars Betting Odds: One Battle After Another Favored for Best Picture
  • Allen Field Co., Inc. Components Selected for Esko ArtiosCAD 3D Component Library
  • Thirteen Reasons Why Gyminny Kids Is San Diego's Best Gymnastics Gym
  • Heritage At Manalapan - A New Luxury Single Family Home Community Coming Late 2025
  • The Lashe® Announces Exclusive November Savings for Lash and Beauty Professionals
  • Corcoran DeRonja Real Estate Welcomes Siobhán Simões to Its Growing Team
  • November is Lung Cancer Awareness Month: Screening Saves Aims to Increase Access to Lung Screenings in NC
  • Valeo Health Leads a New Era of Longevity and Preventive Health in the UAE
  • Torch Entertainment Presents The Frozen Zoo

Popular on PennZone

  • New Article by Roy J. Meidinger – Examines Hidden Hidden Healthcare Kickbacks - 424
  • Mensa Foundation's New Science Program Encourages Hands-On Discovery
  • Investing in Greece: Your Definitive Real-Estate FAQ Guide
  • GitKraken Launches Insights to Help Engineering Leaders Quantify AI Impact and Improve Developer Experience
  • Blogging Pioneer Sherry Bennett Celebrates 29 Years Online - From College Blogger to Successful Entrepreneur
  • Crypto Betting Odds 2025: Bookmakers Review Analyzes Market Predictions and Year-End Price Lines
  • 'Wild Hermit Wellness' Has Achieved Bestseller Status in Just 2 Months Since Launch Of Organic Skincare Line
  • Tami Goveia Enters FabOver40, Inspiring Hollywood Legacy for Breast Cancer Cause
  • The OpenSSL Corporation and the OpenSSL Foundation Celebrate the Success of the Inaugural OpenSSL Conference in Prague
  • J French's #1 Album "I Don't Believe in Bad Days" Enters the Grammy Conversation

Similar on PennZone

  • Revenue Expansion, Regulatory Momentum, and a Leadership Position in the $750 Million Suicidal Depression: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • $750 Million Market on Track to $3.35 Billion by 2034: $NRXP Launches First-in-Florida "One Day" Depression Treatment in Partnership with Ampa Health
  • $750 Million Market Set to Soar to $3.35 Billion by 2034 as Florida Launches First-in-Nation One-Day: NRx Pharmaceuticals (N A S D A Q: NRXP) $NRXP
  • U.S. Entrepreneur Anjo De Heus Builds Innovation Bridge Between America and the Gulf
  • Global Innovators Take the Stage at the WorldUpstart Accelerator Showcase in Philadelphia
  • Phinge's Netverse to Redefine Clinical Trial Safety and Data Integrity with Netverse Patented, Hardware-Verified Platform
  • MDRN MUSE Expands Insurance Network Coverage to Include Delta Dental & Cigna
  • New You Smile Dental Implant Center Expands Office
  • Restoration Dental Introduces YOMI Robot for High-Precision Implant Surgery in Oklahoma
  • Dr. Frederic Scheer to Speak at Big Sky AI Forum in Bozeman, Montana
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us